SAXENDA and VICTOZA possess the very same active component, liraglutide, and really should not be utilised collectively or with other GLP-one receptor agonist medicines.Race and ethnicity had no effect on the pharmacokinetics of liraglutide depending on the results of populace pharmacokinetic analyses that provided overweight and obese sufferers of